Improving Heart Disease Risk Assessment in Diabetes and Prediabetes with eGDR

Improving Heart Disease Risk Assessment in Diabetes and Prediabetes with eGDR

People with diabetes or prediabetes face an elevated risk of developing various cardiovascular conditions, including heart disease, stroke, and congestive heart failure. One crucial factor contributing to this increased risk is how well the body utilizes insulin, which can be measured using the estimated glucose disposal rate (eGDR). A lower eGDR score indicates a poorer ability to process insulin and is associated with a higher likelihood of developing heart-related complications.

Ivabradine’s Role in Heart Failure Management: Insights from a 2024 Meta-Analysis

Ivabradine’s Role in Heart Failure Management: Insights from a 2024 Meta-Analysis

The meta-analysis revealed that Ivabradine led to an average heart rate reduction of about 11.7 beats per minute compared to placebo treatment. This finding was consistent across different age groups, showing similar benefits in both younger and older patients. The study compiled data from 1,687 participants across 11 randomized clinical trials, with 862 patients receiving Ivabradine and 825 receiving placebo treatment.

The Spleen’s Hidden Role in Heart Health

The Spleen’s Hidden Role in Heart Health

The study can provide useful information to interventional cardiologists performing PCI with new-generation DES in AMI patients, regarding the importance of hyperglycemia (especially prediabetes) and the relationship with worse cardiovascular outcomes after both high intensity and low-moderate-intensity statin treatment

Silent Danger: The Impact of Early Pregnancy Hypertension on Mothers and Babies

Silent Danger: The Impact of Early Pregnancy Hypertension on Mothers and Babies

The study can provide useful information to interventional cardiologists performing PCI with new-generation DES in AMI patients, regarding the importance of hyperglycemia (especially prediabetes) and the relationship with worse cardiovascular outcomes after both high intensity and low-moderate-intensity statin treatment

The Best Body Measurements for Hypertension Risk Assessment

The Best Body Measurements for Hypertension Risk Assessment

The study can provide useful information to interventional cardiologists performing PCI with new-generation DES in AMI patients, regarding the importance of hyperglycemia (especially prediabetes) and the relationship with worse cardiovascular outcomes after both high intensity and low-moderate-intensity statin treatment